Respondent burden has been defined as the cumulative demand placed on study participants related to the use of questionnaires or measurement instruments. The aim of this study was to reduce respondent burden associated with the Functional Assessment of Cancer Therapy-Melanoma (FACT-M), a melanoma-specific quality-of-life questionnaire, through item reduction using multiple psychometric approaches. Data for this study were pooled from three institutional review board-approved protocols. Poorly performing items were identified through distributional and correlation analyses, confirmatory factor analysis, reliability estimation, and Rasch-based approaches in a developmental dataset, and the reduced scale was assessed in a separate testing cohort. Validity, reliability, goodness of fit, and Rasch-based testing were carried out for both the full and the reduced scales. The clinical characteristics of the development (n = 198) and testing (n = 204) cohorts were similar. Three items identified through classical psychometric approaches and three items identified by Rasch-based analyses were excluded from the FACT-M subscale. Two additional items were identified for potential reduction but were ultimately maintained due to the adverse consequences to the psychometric integrity of the reduced instrument. The reduced FACT-M module contains 18 items. In addition to psychometric assessment, expert consultation was essential when examining areas of content redundancy and was critical when considering specific items for removal. This methodological approach reduced respondent burden by 25% while maintaining the psychometric integrity of the FACT-M.
Introduction
Health-related quality-of-life (HRQOL) questionnaires are multidimensional instruments used to assess domainrelated health status [1] . The Functional Assessment of Chronic Illness and Therapy is an outcome measurement system composed of a core questionnaire for patients with cancer, the Functional Assessment of Cancer Therapy-General (FACT-G), and a disease-specific module [2] [3] [4] . The FACT-Melanoma (FACT-M) includes a melanoma module comprised of a total of 24 items (www.facit.org) that can be administered as two separate subscales [i.e. the Melanoma Subscale (MS) and the Melanoma Surgical Subscale (MSS)]. The MS contains 16 items assessing general HRQOL in three domains (physical well-being, 12 items; emotional well-being, three items; and social well-being, one item). The MSS assesses surgery-specific concerns, with eight items related to treatment of the primary tumor site, which is particularly relevant to patients with localized disease (stages I/II) [5] . The summary score from the FACT-M module has been validated as an independent measure or can be combined with the FACT-G as a measure of overall cancer-related quality-of-life [6] .
Although the FACT-M has demonstrated strong internal consistency and high test-retest reliability, [6] issues related to patient respondent burden have been increasingly acknowledged [7] . Respondent burden has been defined as the cumulative demand placed on study participants related to the use of questionnaires or surveys [7] . Respondent burden can be particularly problematic for patients who are incapacitated due to advanced disease or who are subjected to repeated survey administration. Less complex quality-of-life questionnaires that require minimal time for completion are highly desirable [8, 9] as excessive imposed burden on clinical trial participants can undermine both response rates and data quality [2, 8, 10, 11] . To increase the clinical utility of the FACT-M, our group sought to lower respondent burden by reducing the number of items while maintaining the psychometric integrity of the instrument.
Methods
Quality-of-life data collected using the FACT-M were pooled from three institutional review board-approved prospective studies. The first study (2006-present) involves the collection of FACT-M data with assessments of limb volume over time for melanoma. The second group includes melanoma patients enrolled in a study (2008) (2009) ) to assess immune responses to peptide vaccines. The third dataset includes melanoma patients (2004) (2005) (2006) who participated in the validation study of the FACT-M. The data from these three studies were pooled and then distributed randomly into a developmental and validation dataset with an equal distribution of stages I/II, stage III, and stage IV patients. The validation cohort was used to compare and confirm the performance of the full and reduced models.
Because the FACT-G and the melanoma module assess overlapping domains, the first phase of analyses aimed to identify and eliminate redundancies and poorly performing items. Pearson's bivariate correlation analysis was used to identify items from the melanoma module that were highly correlated (and therefore redundant) with the FACT-G items. Items with statistically significant correlations of 0.7 or greater were excluded. In addition, univariate analysis identified items from the MS and MSS that exhibited extremely low variability as an indicator of a poorly discriminating item.
The second phase of the analysis explored the possibility of shortening the instrument using both classical and more modern psychometric techniques. First, a confirmatory factor analysis using the development dataset was performed to confirm the domain structure identified in the previous FACT-M validation study [5] . A comparative fit index (CFI) value of at least 0.95 [12] and a root mean square error of approximation (RMSEA) fit statistic value of 0.05 or less [13] were considered indicative of good fit. Next, a Rasch measurement-based approach was performed using Winsteps (version 3.66) software (Chicago, Illinois, USA) [14] . Dimensionality of the underlying traits was assessed, and if unidimensionality for the full FACT-M scale did not hold sufficiently for Rasch analysis, MS and MSS would be analyzed separately. We fit a partial credit model, which is a widely used Rasch model for polytomous items such as those encountered on the FACT-M, to allow the thresholds between categories to be item specific -that is, the relative distance on the latent scale for one item was not required to be uniform across all items [15] . Infit and outfit mean squares were used to assess item fit, as the infit statistic is more sensitive to the unexpected behavior of items located near the subjects HRQOL, whereas the outfit statistic is sensitive to the unexpected behavior of items that are located far from the participant's quality-of-life level. Typically, items with infit or outfit statistics between 0.7 and 1.3 are maintained; [16] however, because this scale ultimately was not scored according to Rasch scoring and there were competing considerations such as item reliability or content coverage, our assumption was that an item could be retained even if the infit or the outfit statistic was as high as 2.0. Reliability and separation indices were also used to evaluate the Rasch measure. If exclusion of the item resulted in more than 20% of the sample having extreme scores, indicating a ceiling or floor effect, the item was retained regardless of fit.
After excluding poorly performing items, the reduced scale was tested using the validation dataset. Goodness of fit was again assessed using the CFI and RMSEA. Internal reliability was evaluated using Cronbach's a for both the full and the reduced scales. Rasch analysis was performed on the validation dataset for the full and reduced scales to assess the robustness of fit.
Results
From the combined groups of patients (n = 458), 56 were excluded from the item-reduction analysis due to incomplete survey responses. The analytic cohort (n = 402) was predominantly white (97%), with a slight majority of men (56%). Similar distributions across demographic and clinical characteristics were observed for respondents in the developmental (n = 198) and testing (n = 204) datasets ( Table 1 ).
The initial phase of analysis revealed that item 16 (I feel fatigued) of the melanoma module was highly correlated (r = 0.703, P < 0.001) with item 1 of the FACT-G (I have a lack of energy). Item 16 was also noted to have a high percentage of missing values (37%), and was excluded before analysis due to redundancy. Items 7 (I have had fevers) and 11 (I have noticed blood in my stool) of the melanoma module exhibited extremely low variability, with 96 and 99% of participants responding 'not at all' for the two items, respectively. Because of this low variability, items 7 and 11 were also excluded before the next phase of analysis.
Confirmatory factor analysis showed that a three-factor model (one factor for the MSS and two correlated physical and psychosocial factors comprising the MS) resulted in poor-fit statistics (w 2 = 153.2, d.f. = 76, P < 0.001, CFI = 0.791, RMSEA = 0.077). When performing a Rasch analysis, principal component analysis of the residuals revealed that there was a strong secondary factor present in the data (3.6 eigenvalue units, which is greater than the 1.6 eigenvalue units expected if the data were unidimensional). This finding, along with support from the scoring manuals of the FACT-M recommending separate subscale scoring, led to separate analyses of the MS and MSS to satisfy the unidimensionality assumption necessary for Rasch analysis.
Rasch analysis of the MS revealed that item 9 (I have a good appetite) had disordered response categories, which violates the intended property of the item and the scale; thus, it was excluded. Item 3 (I worry about the appearance of surgical scars) also exhibited disordered categories, but collapsing the lowest two response categories into one ameliorated this finding; thus, the item was retained. Item 10 (I have aches and pains in my bones) had high infit and outfit statistics (1.47 and 1.55, respectively) and was also excluded. Exclusion of any additional items resulted in more than 20% of the participants in the training dataset having extreme scores, and the infit and outfit statistics of the remaining items were all less than 2.0 ( Table 2) .
Rasch analysis of the MSS revealed that item 24 (I have a good range of motion in my arm or leg), a reverse coded item, had disordered categories. As disordered categories violate scale and item assumptions, this item was excluded. Item 23 (I feel numbness at my surgical site) was identified through Rasch analysis fit statistics. Principal component analysis of the residuals indicated that this item fit a separate dimension from the other items. However, exclusion of this item resulted in more than 50% of respondents having extreme scores for this subscale. This item also behaved well in terms of the category response frequencies and the Rasch category thresholds; thus, item 23 was retained. In total, six items (items 7, 9, 10, 11, 16, and 24) were excluded from the scales. Confirmatory factor analysis was used to verify that the factor structure of the original melanoma module was maintained in the reduced scale with acceptable measures of fit from the training data (w 2 = 268.9, P < 0.001, CFI = 0.975, RMSEA = 0.078).
The final phase of the study involved assessing the performance of the full and reduced scales on the validation dataset. Confirmatory factor analysis revealed that the melanoma-specific items of the reduced FACT-M exhibited acceptable fit (w 2 = 224.0, P < 0.001, CFI = 0.981, RMSEA = 0.070) and better fit than the original melanoma specific items. Reliability estimates were also compared between the full and the reduced scales (Table 3 ). Cronbach's a values for the MS and the MSS were excellent for the full and the reduced scales (all Z 0.90). Reliability remained high for the FACT-M total scores, defined as the FACT-G items scored with the MS and MSS subscales of the FACT-M module (a = 0.97 for the full and reduced scales). The item reliability decreased from 0.96 to 0.79 in the MS and from 0.92 to 0.78 in the MSS. Although the fit statistics are noticeably higher for items 2 and 3 and are within acceptable limits for item 10 (which was excluded for the training data), the overall Rasch fit statistics from the validation dataset were within acceptable limits and confirm the results from the training data. Correlations between the full and the reduced FACT-M were very high (r = 0.997 and 0.996 for the training and validation datasets, respectively), confirming the criterion validity of the reduced instrument. Figure 1 presents the multiple scatter plots comparing the performance of the full and reduced scales in multiple contexts (i.e. combined melanoma module, Item 16 was not included in the reliability analysis due to missing values, and person and item reliability are calculated on the full scale with 13 items after excluding items 7, 11, and 16 in the initial phase of the analysis. They are not calculated for the total Functional Assessment of Cancer Therapy-Melanoma (FACT-M) or for the Melanoma module, because these estimates may be artificially inflated by multidimensionality. MS, MSS, and total FACT-M). These plots demonstrate that the score distributions for the full and reduced scales are very similar.
Discussion
The reduced FACT-M retains 18 of the original 24 items without compromising the psychometric integrity of the original instrument; the reliability and factor structure of the original FACT-M were maintained as was the content validity. The method used was an iterative process that entailed examining both the performance characteristics of individual items and the effects of removing specific items on the overall functioning of the instrument. Our methods capitalized on the strengths of multiple psychometric approaches. For example, Rasch models assume that a single, unidimensional trait drives item response. We were able to assess this assumption before implementing Rasch analysis using classical test theory (CTT). A typical test for unidimensionality in Rasch analysis uses CTT by performing a principal component analysis on the residuals (after the primary dimension is removed). If the residual contrasts identify nonrandom factors, this is evidence of multidimensionality. Another important strength of the analysis presented lies in the validation process that was carried out in a separate cohort of patients -an important but often overlooked step that produces better measures of construct validity and reliability [17] .
In addition to the assessments of data dimensionality, the statistical methods of CTT offer several key strengths. Compared with item-response models like those in Rasch analysis, CTT models are less mathematically complex, and as such, it is easier to satisfy the statistical assumptions required for analysis and to overcome the traditional weaknesses associated with moderate sample sizes [18] . CTT also facilitates straightforward analysis of precision with separate summary estimates for the observed scores and the expected level of error from their 'true' scores that are easily interpretable [18] .
Although some consider Rasch measurement a type of item response theory approach, there are those who argue it is a separate measurement philosophy with its own benefits [19] [20] [21] . In either case, a Rasch measurement approach offers several advantages over the classical psychometric strategies. Specifically, Rasch measurement models assess item and person scores independently, calibrate them to the same scale, and provide modeldriven fit statistics for individual items that can be used to identify poorly performing items [19, 21, 22] . The reliability index is analogous to Cronbach's a and measures the reproducibility of the person's scores.
Although the item reliability index has no analog in classical psychometrics, it has an interpretation similar to the person reliability; item reliability is a measure of the reproducibility of the item parameter estimates. Items are generally considered poorly fitting when they have infit or outfit statistics larger than 1.3 or lower than 0.7 [16] .
The Rasch analysis revealed that the item reliability, although relatively high for the full scale, reduces to more moderate values for the shortened scale. Further inspection, however, revealed that the high item reliability for the full scale is strongly influenced by a poorly performing item in both subscales (items 9 and 24). Because these items were both reverse-coded and the scores did not increase monotonically as the categories increased, these two items may have artificially inflated the item reliability of the original scale.
Through this item reduction process, each of the HRQOL domains was maintained in the reduced instrument. Others have similarly found that an iterative and multifaceted approach can lead to a substantial reduction in respondent burden without major sacrifices in the psychometric integrity of the instrument [23] [24] [25] [26] . Meads and Bentall [25] used elements of CTT and Rasch analysis when identifying items for potential reduction from a psychological measure of hypomania. More directly related to cancer, a recent CTT-driven analysis was successfully undertaken for the 11-item FACT/Gynecologic Oncology Group Neurotoxicity subscale (FACT/ GOG-Ntx) to reduce respondent burden for patients with endometrial cancer, resulting in a substantially reduced four-item short form [24] . Likewise, Prieto et al. in a study of HRQOL compared the results of separate CTT and Rasch-based analyses reducing a generic measure of health status to a short-form version [26] .
Conclusion
Reducing respondent burden by shortening established quality-of-life instruments is a multiphased methodological process. Comprehensive assessment of patient HRQOL is particularly important in the context of clinical research, where the burden of participation may vary by intensity and degree according to the participant's condition, prognosis, mental state, and support systems [27] . Shorter and less complex HRQOL instruments that maintain sufficient psychometric integrity for research purposes are therefore more desirable, particularly given that excessive burden can undermine questionnaire response and data quality [8] .
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